6505--Bumetanide Tablets (VA-26-00011200)

This solicitation (36E79725R0068) requires offerors to furnish pricing for a base year and five option years for specified line items, including a 0.50% Cost Recovery Fee. Proposals must include all projected subcontracting dollars, both large and small businesses, and may be rejected if pricing is incomplete or required representations are missing. A critical requirement is that all proposed covered drug products/NDCs must be present on the offeror’s FSS contract or interim agreement with an established Permanent FCP by the offer due date. Offerors are required to submit a subcontracting plan detailing methods used to identify potential sources and justification for any proposed goals below VA suggested goals or last year’s achievements. The deadline for receipt of offers has been extended to November 20, 2025, at 2:30 PM CST. Contractors must also accurately report all contract sales quarterly and submit collected Cost Recovery Fees.

Notice ID

93bb80ed44454fd49a73ce4237730283

Solicitation Number

36E79725R0068

NAICS Code

325412

Classification Code

6505